Researchers Use New Technique to Identify A Novel Drug Combination for NSCLC

03 Oct, 2018 ,
H. Lee Mofiftt Cancer Centre & Research Institute
Source
H. Lee Mofiftt Cancer Centre & Research Institute
03 Oct, 2018 ,

Researchers are combining the largescale study of proteins with new data integration method to identify a previously unknown mechanism for midostaurin in lung cancer They design a combination therapy using midostaurin and BI2536 a protein inhibitor currently being investigated for the treatment of multiple cancers which had a much greater effect on reducing NSCLC growth than using either drug alone

Source